The Metabolic Phenotype of Youth Onset Type 2 Diabetes: The Role of Pregestational Diabetes Exposure and the Hepatic Nuclear Factor 1Alpha G319S Polymorphism

Canadian Journal of Diabetes

Volumn 40, Issue 3, 2016, Pages 210-215

  Charison, Jodie ^a   Wicklow, Brandy A ^a,b   Dean, Heather J ^a,b   Sellers, Elizabeth A C ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

adolescents; metabolic phenotype; type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HNF1A PROTEIN, HUMAN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIRTH WEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GESTATIONAL AGE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY DIABETES MELLITUS; PRENATAL EXPOSURE; PROTEIN POLYMORPHISM; RETROSPECTIVE STUDY; SEX DIFFERENCE; WAIST CIRCUMFERENCE; ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 2; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PHENOTYPE; PREGNANCY;

ADOLESCENT; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES;

EID: 84979916816     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2015.10.003     Document Type: Article

References (34)

1. 1 Fagot-Campagna, A., Emergence of type 2 diabetes mellitus in children; epidemiological evidence. JPEM 13:Suppl. 6 (2000), 1395–1402.
2. 2 Amed, S., Dean, H.J., Panagiotopoulos, C., et al. Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: A prospective national surveillance study. Diabetes Care 34 (2010), 786–791.
3. 3 Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea, D., Bell, R.A., et al. Incidence of diabetes in youth in the United States. JAMA 97 (2007), 2716–2724.
4. 4 Sellers, E.A.C., Wicklow, B.A., Dean, H.J., Clinical and Demographic Characteristics of Type 2 Diabetes in Youth at Diagnosis in Manitoba and Northwestern Ontario (2006–2011). Can J Diabetes 36 (2012), 114–118.
5. 5 Diabetes Education Resource for Children and Adolescents. Annual Report 2012. Winnipeg Regional Health Authority, 2012.
6. 6 Nadeau, K., Dabelea, D., Epidemiology of type 2 diabetes in children and adolescents. Endocr Res 33 (2008), 35–58.
7. 7 Pettitt, D.J., Aleck, K.A., Baird, H.R., et al. Congenital susceptibility to NIDDM: Role of intrauterine environment. Diabetes 37 (1988), 622–628.
8. 8 Young, T.K., Martens, P.J., Taback, S.P., et al. Type 2 diabetes mellitus in children: Prenatal and early infancy risk factors among native Canadians. Arch Pediatr Adolesc Med 156 (2002), 651–655.
9. 9 El Mallah, K.O., Narchi, H., Kulaylat, N.A., et al. Gestational and pre-gestational diabetes: Comparison of maternal and fetal characteristics and outcome. Int J Gynecol Obstet 58 (1997), 203–209.
10. 10 Vambergue, A., Fajardy, I., Consequences of gestational and Pregestational diabetes on placental function and birthweight. World J Diabetes 2 (2011), 196–203.
11. 11 Pontoglio, M., Sreenan, S., Roe, M., et al. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J Clin Invest 101 (1998), 2215–2222.
12. 12 Okita, K., Yang, Q., Yamagata, K., et al. Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta. Biochem Biophys Res Commun 263 (1999), 566–569.
13. 13 Yang, Q., Yamagata, K., Yamamoto, K., et al. Structure/ function studies of hepatocyte nuclear factor-1alpha, a diabetes-associated transcription factor. Biochem Biophys Res Commun 266 (1999), 196–202.
14. 14 Hegele, R.A., Cao, H., Harris, S.B., et al. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 84 (1999), 1077–1082.
15. 15 Harris, S.B., Gittelsohn, J., Hanley, A., et al. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 20 (1997), 185–187.
16. 16 Harries, L.W., Sloman, M.J., Sellers, E.A., et al. Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts. Diabetes 57 (2008), 1978–1982.
17. 17 Hegele, R.A., Cao, H., Harris, S.B., et al. Gender, obesity, hepatic nuclear factor-1alpha G319 and the age-of-onset of type 2 diabetes in Canadian Oji-Cree. Int J Obes Relat Metab Disord 24 (2000), 1062–1064.
18. 18 Sellers, E.A.C., Triggs-Raine, B., Rockman-Greenberg, C., et al. The prevalence of the HNF-1α G319S mutation in Canadian aboriginal youth with type 2 diabetes. Diabetes Care 25 (2002), 2202–2206.
19. 19 Dart, A.B., Martens, P.J., Sellers, E.A., et al. Validation of a pediatric diabetes case definition using administrative health data in Manitoba, Canada. Diabetes Care 34 (2011), 898–903.
20. 20 Panagiotopoulos, C., Riddell, M.C., Sellers, E.A.C., Type 2 diabetes in children and adolescents. Can J Diabetes 37:Suppl. 1 (2013), S163–7.
21. 21 Sellers, E., Eisenbarth, G., Young, T.K., et al. Diabetes-associated autoantibodies in aboriginal children [letter]. Lancet, 355, 2000, 1156.
22. 22 Centers for Disease Control and Prevention, National Center for Health Statistics, CDC growth charts: United States. http://www.cdc.gov/growthcharts/ Accessed July 23, 2012.
23. 23 The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. https://www.nhlbi.nih.gov/files/docs/resources/heart/hbp_ped.pdf Accessed July 23, 2012.
24. 24 McCarthy, H.D., Jarrett, K.V., Crawley, H.F., Original communication: The development of waist circumference percentiles in British children aged 5.0–16.9 y. Eur J Clin Nutr 55 (2001), 902–907.
25. 25 R Core Team, R:a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria http://www.R-project.org/, 2013 Accessed February 4, 2014.
26. 26 Fox, J., Weisberg, S., An R companion to allied regression. 2011, Sage Press, London.
27. 27 Han, J., Xu, J., Long, Y.S., et al. Rat maternal diabetes impairs pancreatic beta-cell function in the offspring. Am J Physiol Endocrinol Metab 293 (2007), 228–236.
28. 28 Kamel, M.A., Helmy, M.H., Hanafi, M.Y., et al. Impaired peripheral glucose sensing in F1 offspring of diabetic pregnancy. J Physiol Biochem 70 (2014), 685–699.
29. 29 Desoye, G., Hauguel-de Mouzon, S., The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30:Suppl. 2 (2007), S120–6.
30. 30 Wahrenberg, H., Hertel, K., Leijonhufvud, B.M., et al. Use of waist circumference to predict insulin resistance; retrospective study. BMJ 330 (2005), 1363–1364.
31. 31 Triggs-Raine, B.L., Kirkpatrick, R.D., Kelly, S.L., et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci U S A 99 (2002), 4614–4619.
32. 32 Dean, H.J., Mundy, R.L., Moffatt, M., Non-insulin-dependent diabetes mellitus in Indian children in Manitoba. CMAJ 147 (1992), 52–57.
33. 33 Matyka, K.A., Type 2 diabetes in childhood: Epidemiological and clinical aspects. Br Med Bull 86 (2008), 59–75.
34. 34 Amed, S., Hamilton, J.K., Sellers, E.A.C., et al. Differing clinical features in Aboriginal vs. non-Aboriginal children presenting with type 2 diabetes. Pediatr Diabetes 13 (2012), 470–475.